We bring you the latest news from the healthcare about the health care in the United Kingdom.

donderdag 12 april 2018

Oncogene - Table of Contents alert Volume 37 Issue 15

If you are unable to see the message below, click here to view.

RNA-seq has become much, much simpler 

New CATS RNA-seq library preparation 
  • Start-to-finish library preparation in 5 hours - and only 30 minutes hands-on time.
  • Innovative "CATS" technology for reliable library prep down to only 10 picograms input. 
  • Proven to detect more transcripts than any other commercial method -- guaranteed.
Learn more


Volume 37, Issue 15

In this issue
Review Article
Brief Communications
Also new

Review Article

Wild-type and mutated IDH1/2 enzymes and therapy responses

Remco J. Molenaar, Jaroslaw P. Maciejewski, Johanna W. Wilmink & Cornelis J. F. van Noorden

Oncogene 2018 37 :1949 - 1960; January 25, 2018; 10.1038/s41388-017-0077-z

Abstract | Full Text


Hypoxia induces miR-153 through the IRE1a-XBP1 pathway to fine tune the HIF1a/VEGFA axis in breast cancer angiogenesis

Huichun Liang, Ji Xiao, Zhongmei Zhou, Jiao Wu, Fei Ge et al.

Oncogene 2018 37 :1961 - 1975; January 25, 2018; 10.1038/s41388-017-0089-8

Abstract | Full Text

PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation

Angela Russo, Austin A. Czarnecki, Matthew Dean, Dimple A. Modi, Daniel D. Lantvit et al.

Oncogene 2018 37 :1976 - 1990; January 25, 2018; 10.1038/s41388-017-0097-8

Abstract | Full Text

PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma

Jason A. Hanna, Matthew R. Garcia, Alicia Lardennois, Patrick J. Leavey, Dino Maglic et al.

Oncogene 2018 37 :1991 - 2007; January 25, 2018; 10.1038/s41388-017-0081-3

Abstract | Full Text

Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer

Alacoque L. Browne, Sara Charmsaz, Damir Varešlija, Ailis Fagan, Nicola Cosgrove et al.

Oncogene 2018 37 :2008 - 2021; January 25, 2018; 10.1038/s41388-017-0042-x

Abstract | Full Text

Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer

Lucy Ireland, Almudena Santos, Fiona Campbell, Carlos Figueiredo, Dean Hammond et al.

Oncogene 2018 37 :2022 - 2036; January 25, 2018; 10.1038/s41388-017-0115-x

Abstract | Full Text

Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production

Hiroyasu Konno, Shota Yamauchi, Anders Berglund, Ryan M. Putney, James J. Mulé et al.

Oncogene 2018 37 :2037 - 2051; January 25, 2018; 10.1038/s41388-017-0120-0

Abstract | Full Text

CHTM1, a novel metabolic marker deregulated in human malignancies

Mansi Babbar, Ying Huang, Jie An, Steve K. Landas & M. Saeed Sheikh

Oncogene 2018 37 :2052 - 2066; January 26, 2018; 10.1038/s41388-017-0051-9

Abstract | Full Text

Brief Communications

ROS release by PPARß/d-null fibroblasts reduces tumor load through epithelial antioxidant response

Eddie Han Pin Tan, Ming Keat Sng, Ivan Shun Bo How, Jeremy Soon Kiat Chan, Jiapeng Chen et al.

Oncogene 2018 37 :2067 - 2078; January 25, 2018; 10.1038/s41388-017-0109-8

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature